MARY DANIEL: Open Payments
NPI 1073836466 · CENTERTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 65 payments from 17 companies in 2025. Trend: 2023 $1,242 · 2024 $1,043 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $311 |
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Novo Nordisk Inc | 6 | $113 |
| PFIZER INC. | 5 | $95 |
| Lilly USA, LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Amgen Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $40 |
Products named: QULIPTA, AIRSUPRA, NURTEC ODT, Ozempic, UBRELVY, VOQUEZNA, JARDIANCE, MOUNJARO.
Industry payments across AR — which companies pay providers there.
